Dr Ana-Mishel Spiroski

Dr. Ana-Mishel (AM) Spiroski serves as the Cardiovascular Therapeutic Area Lead and Group Leader in In Vivo Pharmacology at Evotec since October 2021. With a strong background in biomedical science, Spiroski transitioned from a life science consultant specializing in preclinical therapeutic candidate development and disease modeling from 2016 to 2021. Previous roles include Research Fellow and Lecturer at The University of Edinburgh, focusing on cardiac and vascular regenerative medicine, as well as positions at the University of Cambridge and the Liggins Institute, where Spiroski led research in therapeutics and community health interventions. Dr. Spiroski's educational credentials include a PhD in Biomedical Science from The University of Auckland and dual master's and bachelor's degrees from the University of Montana.